INFY:NYSEInfosys Limited Analysis
Data as of 2026-07-23 - not real-time
$10.93
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Infosys is trading at $10.93, comfortably above the 30‑day support of $10.34 but well below its 20‑day SMA of $11.02 and 50‑day SMA of $11.69, indicating a short‑term bearish bias. Technical signals show a bearish trend direction, yet the MACD histogram is positive, hinting at a potential near‑term bounce. Fundamentally, the stock appears undervalued with a trailing P/E of 14 versus an industry average of 34 and a DCF‑derived fair value of $14.06, implying roughly 20% upside. The company delivers a robust 4.69% dividend yield on a 64% payout ratio, supported by $3.17 bn of free cash flow and a 31% ROE, suggesting dividend sustainability. Revenue is growing at 6.6% YoY and operating margins sit near 21%, reinforcing a solid earnings base. However, volatility is high at nearly 50% over the past month, though beta is modest at 0.47, reflecting limited market‑wide sensitivity. Upcoming Q1 FY27 results add earnings uncertainty, which could swing the stock in either direction in the near term.
Long‑run, Infosys benefits from AI‑focused service expansions and a diversified client base across multiple industries, positioning it for steady growth. The combination of a low beta, stable liquidity (average daily volume ~22.5 M shares), and a strong balance sheet (cash > $3.7 bn, debt under $1 bn) mitigates many risks, while the attractive dividend and valuation cushion provide downside protection for patient investors.
Long‑run, Infosys benefits from AI‑focused service expansions and a diversified client base across multiple industries, positioning it for steady growth. The combination of a low beta, stable liquidity (average daily volume ~22.5 M shares), and a strong balance sheet (cash > $3.7 bn, debt under $1 bn) mitigates many risks, while the attractive dividend and valuation cushion provide downside protection for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish SMA alignment
- Upcoming earnings release adds near‑term uncertainty
- High 30‑day volatility despite low beta
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervaluation relative to peers and DCF fair value
- Strong cash generation and sustainable dividend yield
- Projected earnings growth from AI and digital services
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust ROE and operating margins supporting durable profitability
- Strategic positioning in high‑growth AI and cloud services
- Low beta and solid balance sheet offering resilience over time
Key Metrics & Analysis
Financial Health
Revenue Growth6.60%
Profit Margin16.43%
P/E Ratio14.0
ROE31.44%
ROA15.09%
Debt/Equity9.83
P/B Ratio9.0
Op. Cash Flow$4.0B
Free Cash Flow$3.2B
Industry P/E33.7
Technical Analysis
TrendBearish
RSI44.6
Support$10.34
Resistance$11.58
MA 20$11.02
MA 50$11.69
MA 200$14.87
MACDBullish
VolumeStable
Fear & Greed Index90.45
Valuation
Fair Value$14.06
Target Price$13.11
Upside/Downside19.90%
GradeUndervalued
TypeBlend
Dividend Yield4.69%
Risk Assessment
Beta0.47
Volatility49.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.